January 30, 2024
January 30, 2024
BOSTON, MASS. (November 7, 2023) ā Colby Davis of Boston, creating pendants, necklaces and other fine jewelry inspired by moments of everyday life, has selected Cure Alzheimerās Fund as the beneficiary of its Pendants with a Purpose campaign for November 2023 The āPendants with a Purposeā campaign launched in October 2023, ...
November 13, 2023
From October 23 through October 27, leading generative art platform Art Blocks will be hosting an exclusive auction of works by five leading artists worldwide. With every day of the week designated to a different artist, the auction sets out to unite artists and collectors in the fight against neurodegenerative ...
October 7, 2023
A physician canāt cure what he canāt diagnose. The diagnosis of Alzheimer’s disease is based on the exclusion of several neurological syndromes, rather than directly testing for the disease of interest. This can be an inaccurate exercise in up to 20% of the cases. Promising biomarkers are being developed, such ...
January 31, 2013
Microglia are the innate immune cells that reside in the central nervous system and remove unwanted particles and debris from the brain. TREM2 is a receptor found on microglia and its activation increases amyloid beta uptake; the effect is therefore neuroprotective. An antibody designed to increase TREM2 activation has shown ...
October 7, 2022
A new Alzheimer’s disease (AD) model suggests that defects in the blood-brain barrier (BBB) play a key role in worsening amyloid plaques and neurofibrillary tangles, and that therapies to reduce gaps in the BBB hold promise for treatment of the disease. The new model uses āmicrofluidicsā to examine how a layer ...
October 9, 2019
At Cure Alzheimerās Fund, one of our successful strategies is to fund research that is innovative and based on high-quality science yet deemed risky by traditional funding sources. Our entrepreneurial approach and ability to provide funds in a quick and efficient manner allows us to fund potentially groundbreaking work that ...
December 15, 2010
To mark the 40th anniversary of the Science section of The New York Times, the editors made a list of their 11 most pressing science questions they would like answered in the coming years. Given the scale of Alzheimerās diagnosis in the United States, it is no surprise that the ...
December 13, 2018
Setting the stage The 10th Annual International Conference on Alzheimerās Disease/Parkinsonās Disease (AD/PD) was held this March in Barcelona with thousands of researchers from 68 countries attending. Chief among the topics of interest was determining risk for the disease from genetics. The useful source for all things Alzheimerās, The Alzheimerās Research ...
April 7, 2011
January 30, 2024